 |
PDBsum entry 2feh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
2feh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.2.1.12
- glyceraldehyde-3-phosphate dehydrogenase (phosphorylating).
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Glyceraldehyde-3-phosphate Dehydrogenase (phosphorylating)
|
 |
 |
 |
 |
 |
Reaction:
|
 |
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = (2R)-3-phospho- glyceroyl phosphate + NADH + H+
|
 |
 |
 |
 |
 |
D-glyceraldehyde 3-phosphate
|
+
|
phosphate
|
+
|
NAD(+)
|
=
|
(2R)-3-phospho- glyceroyl phosphate
|
+
|
NADH
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
62:290-301
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase.
|
|
J.L.Jenkins,
J.J.Tanner.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
GAPDH (D-glyceraldehyde-3-phosphate dehydrogenase) is a multifunctional protein
that is a target for the design of antitrypanosomatid and anti-apoptosis drugs.
Here, the first high-resolution (1.75 Angstroms) structure of a human GAPDH is
reported. The structure shows that the intersubunit selectivity cleft that has
been leveraged in the design of antitrypanosomatid compounds is closed in human
GAPDH. Modeling of an anti-trypanosomatid GAPDH inhibitor in the human GAPDH
active site provides insights into the basis for the observed selectivity of
this class of inhibitor. Moreover, the high-resolution data reveal a new feature
of the cleft: water-mediated intersubunit hydrogen bonds that assist closure of
the cleft in the human enzyme. The structure is used in a computational
ligand-docking study of the small-molecule compound CGP-3466, which inhibits
apoptosis by preventing nuclear accumulation of GAPDH. Plausible binding sites
are identified in the adenosine pocket of the NAD(+)-binding site and in a
hydrophobic channel located in the center of the tetramer near the intersection
of the three molecular twofold axes. The structure is also used to build a
qualitative model of the complex between GAPDH and the E3 ubiquitin ligase
Siah1. The model suggests that the convex surface near GAPDH Lys227 interacts
with a large shallow groove of the Siah1 dimer. These results are discussed in
the context of the recently discovered NO-S-nitrosylation-GAPDH-Siah1 apoptosis
cascade.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 7.
Figure 7 Structures of HsGAPDH and Siah1 highlighting regions
that are important for GAPDH-Siah1 association. (a) HsGAPDH
tetramer viewed down the R axis. Subunits are colored as
follows: O, yellow; P, red; Q, green; R, blue. Residues that are
essential for complex formation with Siah1 are colored gray
(residues 222-240) and atoms of Lys227 are drawn as spheres. (b)
Homodimer of Siah1 from PDB entry 1k2f (Polekhina et al.,
2002[Polekhina, G., House, C. M., Traficante, N., Mackay, J. P.,
Relaix, F., Sassoon, D. A., Parker, M. W. & Bowtell, D. D.
(2002). Nature Struct. Biol. 9, 68-75.]). The two subunits of
Siah1 are colored cyan and violet. Residues that are essential
for interaction with GAPDH are colored yellow (residues 270-282).
|
 |
Figure 8.
Figure 8 Qualitative model of the HsGAPDH-Siah1 complex. (a)
Docked complex having the top score from PatchDock. A GAPDH
subunit is shown in green and the Siah1 dimer is shown in
cyan/violet. Only one subunit of the GAPDH dimer used for
docking is shown for clarity. GAPDH residues 222-240 are colored
gray. Siah1 residues 270-282 are colored yellow. GAPDH Lys227
and Siah1 Ser280 are drawn as spheres. (b) Model of a GAPDH
tetramer interacting with four Siah1 dimers. This model was
generated from the model in (a) using the symmetry of the GAPDH
tetramer. The view is looking down the GAPDH R axis. GAPDH
subunits are colored as follows: O, yellow; P, red; Q, green; R,
blue. Siah1 dimers are colored cyan/violet and salmon/slate. (c)
Surface representation of the model shown in (b).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the IUCr:
Acta Crystallogr D Biol Crystallogr
(2006,
62,
290-301)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.A.Butterfield,
S.S.Hardas,
and
M.L.Lange
(2010).
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.
|
| |
J Alzheimers Dis,
20,
369-393.
|
 |
|
|
|
|
 |
K.A.Chernorizov,
J.L.Elkina,
P.I.Semenyuk,
V.K.Svedas,
and
V.I.Muronetz
(2010).
Novel Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase: Covalent Modification of NAD-Binding Site by Aromatic Thiols.
|
| |
Biochemistry (Mosc),
75,
1444-1449.
|
 |
|
|
|
|
 |
Y.W.Lam,
Y.Yuan,
J.Isaac,
C.V.Babu,
J.Meller,
and
S.M.Ho
(2010).
Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.
|
| |
PLoS One,
5,
e9075.
|
 |
|
|
|
|
 |
J.Frayne,
A.Taylor,
G.Cameron,
and
A.T.Hadfield
(2009).
Structure of insoluble rat sperm glyceraldehyde-3-phosphate dehydrogenase (GAPDH) via heterotetramer formation with Escherichia coli GAPDH reveals target for contraceptive design.
|
| |
J Biol Chem,
284,
22703-22712.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.A.Demarse,
S.Ponnusamy,
E.K.Spicer,
E.Apohan,
J.E.Baatz,
B.Ogretmen,
and
C.Davies
(2009).
Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation.
|
| |
J Mol Biol,
394,
789-803.
|
 |
|
|
|
|
 |
U.Sengupta,
S.Ukil,
N.Dimitrova,
and
S.Agrawal
(2009).
Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.
|
| |
PLoS One,
4,
e8100.
|
 |
|
|
|
|
 |
S.A.Madsen-Bouterse,
and
R.A.Kowluru
(2008).
Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
|
| |
Rev Endocr Metab Disord,
9,
315-327.
|
 |
|
|
|
|
 |
S.Azam,
N.Jouvet,
A.Jilani,
R.Vongsamphanh,
X.Yang,
S.Yang,
and
D.Ramotar
(2008).
Human Glyceraldehyde-3-phosphate Dehydrogenase Plays a Direct Role in Reactivating Oxidized Forms of the DNA Repair Enzyme APE1.
|
| |
J Biol Chem,
283,
30632-30641.
|
 |
|
|
|
|
 |
S.D.Dunn,
L.M.Wahl,
and
G.B.Gloor
(2008).
Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction.
|
| |
Bioinformatics,
24,
333-340.
|
 |
|
|
|
|
 |
H.Kim,
L.Deng,
X.Xiong,
W.D.Hunter,
M.C.Long,
and
M.C.Pirrung
(2007).
Glyceraldehyde 3-phosphate dehydrogenase is a cellular target of the insulin mimic demethylasterriquinone B1.
|
| |
J Med Chem,
50,
3423-3426.
|
 |
|
|
|
|
 |
H.Nakajima,
W.Amano,
A.Fujita,
A.Fukuhara,
Y.T.Azuma,
F.Hata,
T.Inui,
and
T.Takeuchi
(2007).
The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death.
|
| |
J Biol Chem,
282,
26562-26574.
|
 |
|
|
|
|
 |
S.D.Weeks,
M.Drinker,
and
P.J.Loll
(2007).
Ligation independent cloning vectors for expression of SUMO fusions.
|
| |
Protein Expr Purif,
53,
40-50.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |